|
|
| Research article summary (published 30 Oct 2006): |
M1 muscarinic acetylcholine receptor agonism alters sleep without affecting memory consolidation.
Full Abstract
Preclinical studies have implicated cholinergic neurotransmission, specifically M1 muscarinic acetylcholine receptor (mAChR) activation, in sleep-associated memory consolidation. In the present study, we investigated the effects of administering the direct M1 mAChR agonist RS-86 on pre-post sleep memory consolidation. Twenty healthy human participants were tested in a declarative word-list task and a procedural mirror-tracing task. RS-86 significantly reduced rapid eye movement (REM) sleep latency and slow wave sleep (SWS) duration in comparison with placebo. Presleep acquisition and postsleep recall rates were within the expected ranges. However, recall rates in both tasks were almost identical for the RS-86 and placebo conditions. These results indicate that selective M1 mAChR activation in healthy humans has no clinically relevant effect on pre-post sleep consolidation of declarative or procedural memories at a dose that reduces REM sleep latency and SWS duration.
Learn Faster Today Improve your study skills
Author information
Author/s: Nissen, Christoph (C); Power, Ann E (AE); Nofzinger, Eric A (EA); Feige, Bernd (B); Voderholzer, Ulrich (U); Kloepfer, Corinna (C); Waldheim, Bernhard (B); Radosa, Marc-Philipp (MP); Berger, Mathias (M); Riemann, Dieter (D);
Affiliation: Albert-Ludwigs-University Freiburg, Germany. nissenc(-atsign-)upmc.edu
Journal and publication information
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
Journal: Journal of cognitive neuroscience (J Cogn Neurosci), published in United States. (Language: eng)
Reference: 2006-Nov; vol 18 (issue 11) : pp 1799-807
Dates: Created 2006/10/30; Completed 2006/12/12;
PMID: 17069471, status: MEDLINE (last retrieval date: 12/26/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
|
Related articles
These are the highest related articles currently in the database:
- Influence of the cholinergic agonist RS 86 on normal sleep: sex and age effects.
29 Apr 1988 - The cholinergic rapid eye movement sleep induction test with RS-86. State or trait marker of depression?
29 Apr 1989 - Muscarinic agonist therapy of Alzheimer's disease. A clinical trial of RS-86.
29 Jun 1986 - Differential effects of the muscarinic M1 receptor agonist RS-86 and the acetylcholine-esterase inhibitor donepezil on REM sleep regulation in healthy volunteers.
30 May 2006 - Cholinergic and noradrenergic neurotransmission: impact on REM sleep regulation in healthy subjects and depressed patients.
29 Apr 1992 - Sleep, age, depression and the cholinergic REM induction test with RS 86.
29 Apr 1992 - Effects of RS 86, an orally active cholinergic agonist, on sleep in man.
30 Dec 1983 - [Central effect of various new carbamide and succinimide derivatives of benzoxazolone-2]
30 Dec 1980 - 2-(Substituted)amino-2,8-diazaspiro[4,5]decan-1,3-diones as potential muscarinic agonists: synthesis, modeling and binding studies.
29 Sep 1996 - Prediction of the development of a first major depressive episode with a rapid eye movement sleep induction test using the cholinergic agonist RS 86.
30 May 2004
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.